Anand Krishnan Nambisan
Overview
Explore the profile of Anand Krishnan Nambisan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarreiphang H, Vidyadhara D, Nambisan A, Raju T, Sagar B, Alladi P
Mol Neurobiol
. 2023 May;
60(8):4778-4794.
PMID: 37162724
Identification of genetic mutations in Parkinson's disease (PD) promulgates the genetic nature of disease susceptibility. Resilience-associated genes being unknown till date, the normal genetic makeup of an individual may be...
2.
Pougoue Ketchemen J, Babeker H, Tikum A, Nambisan A, Njotu F, Nwangele E, et al.
Br J Cancer
. 2023 Apr;
129(1):153-162.
PMID: 37095184
Background: HER2 is overexpressed in 25-30% of breast cancer. Multiple domains targeting of a receptor can have synergistic/additive therapeutic effects. Methods: Two domain-specific ADCs trastuzumab-PEG-DM1 (domain IV) and pertuzumab-PEG-DM1 (domain...
3.
Babeker H, Pougoue Ketchemen J, Annan Sudarsan A, Andrahennadi S, Tikum A, Nambisan A, et al.
Pharmaceutics
. 2022 Dec;
14(12).
PMID: 36559316
Antibodies that recognize cancer biomarkers, such as MUC16, can be used as vehicles to deliver contrast agents (imaging) or cytotoxic payloads (therapy) to the site of tumors. MUC16 is overexpressed...
4.
Tikum A, Nambisan A, Pougoue Ketchemen J, Babeker H, Khan M, Torlakovic E, et al.
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145664
Matuzumab and nimotuzumab are anti-EGFR monoclonal antibodies that bind to different epitopes of domain III of EGFR. We developed Zr-matuzumab as a PET probe for diagnosis/monitoring of response to treatment...
5.
Saundh S, Patnaik D, Gagne S, Bishop J, Lipsit S, Amat S, et al.
ACS Chem Neurosci
. 2020 Nov;
11(24):4128-4138.
PMID: 33253521
Glycogen synthase kinase 3-beta (GSK3β) is a critical regulator of several cellular pathways involved in neurodevelopment and neuroplasticity and as such is a potential focus for the discovery of new...